Chong Kun Dang Pharmaceutical Corp. launched the nation's first diabetes treatment 'Duvie'
(Yakup Shinmoon)
On Feb 1, Chong Kun Dang Pharmaceutical Corp. launched self-developed the nation's first diabetes treatment 'Duvie'.
'Duvie' (ingredient: lobeglitazone sulfate) is the second new drug of CKD, followed by chemotherapy agent 'Camtobell' (2003). 'Duvie' has been developed si...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
